Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 296 Records) |
Query Trace: FGFR1[original query] |
---|
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
Genetic spectrum of Kallmann syndrome: Single-center experience and systematic review. Clinical endocrinology 2022 9 97 (6): 804-813. Patil Virendra A, Lila Anurag Ranjan, Shah Nalini, Arya Sneha, Sarathi Vijaya, Shah Ravikumar, Jadhav Swati S, Memon Saba Samad, Karlekar Manjiri, Bandgar Tush |
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Significant association between FGFR1 mutation frequency and age in central giant cell granuloma. Pathology 2022 11 . Niada Stefania, Varazzani Andrea, Giannasi Chiara, Fusco Nicola, Armiraglio Elisabetta, Di Bernardo Andrea, Cherchi Alessandro, Baj Alessandro, Corradi Domenico, Tafuni Alessandro, Parafioriti Antonina, Ferrero Stefano, Bianchi Andrea Edoardo, Giannì Aldo Bruno, Poli Tito, Latif Farida, Brini Anna Tere |
Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric dermatology 2023 7 . Kelly K Barry, Marilyn G Liang, Daniel M Balkin, Siddharth Srivastava, Alanna J Church, Whitney E |
Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia. Cancer genetics 2023 7 276-277 43-47. Lisa M Marinelli, Joshua T Romain, William Ehman, Veronica Ortega, Gopalrao Velagaleti, Thomas F Gibbons, Ashley Nazario-Toole, Allen R Holm |
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia 2023 7 . Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, Johannes Lübke, Sebastian Kreil, Alice Fabarius, Claudia Haferlach, Torsten Haferlach, Wolf-Karsten Hofmann, Nicholas C P Cross, Juliana Schwaab, Andreas Reit |
Ethnic Differences in the Brazilian Population Influence the Impact of BMP4 Genetic Variants on Susceptibility of Nonsyndromic Orofacial Clefts. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2023 6 10556656231180086. Lilianny Querino Rocha de Oliveira, Hellen Carolliny de Souza Nicolau, Daniella Reis Barbosa Martelli, Hercílio Martelli-Júnior, Rafaela Scariot, Ana Lúcia Carrinho Ayroza Rangel, Silvia Regina de Almeida Reis, Ricardo D Coletta, Renato Assis Macha |
Genetic Influence of Fracture Nonunion (FNU): A Systematic Review. Pharmacogenomics and personalized medicine 2023 6 16 569-575. Mir Sadat-Ali, Hussain K Al-Omar, Khalid W AlTabash, Ammar K AlOmran, Dakheel A AlDakheel, Hasan N AlSay |
Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes. Molecular oncology 2023 3 . Chen Jessica W, Jacot William, Cortés Javier, Krop Ian E, Dent Susan, Harbeck Nadia, De Laurentiis Michelino, Diéras Véronique, Im Young-Hyuck, Stout Thomas J, Schimmoller Frauke, Savage Heidi M, Hutchinson Katherine E, Wilson Timothy |
Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2023 2 . Hassan Neelam, Gregson Celia L, Tang Haotian, van der Kamp Marc, Leo Paul, McInerney-Leo Aideen M, Zheng Jie, Brandi Maria Luisa, Tang Jonathan C Y, Fraser William, Stone Michael D, Grundberg Elin, , Brown Matthew A, Duncan Emma L, Tobias Jonathan |
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Acta neuropathologica 2023 12 147 (1): 2. Lucie Auffret, Yassine Ajlil, Arnault Tauziède-Espariat, Thomas Kergrohen, Chloé Puiseux, Laurent Riffaud, Pascale Blouin, Anne-Isabelle Bertozzi, Pierre Leblond, Klas Blomgren, Sébastien Froelich, Alberto Picca, Mehdi Touat, Marc Sanson, Kévin Beccaria, Thomas Blauwblomme, Volodia Dangouloff-Ros, Nathalie Boddaert, Pascale Varlet, Marie-Anne Debily, Jacques Grill, David Cast |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Non-Lobular Invasive Breast Carcinomas with Bi-Allelic Pathogenic CDH1 Somatic Alterations: a Histologic, Immunophenotypic and Genomic Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 11 100375. Fatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, Edaise M da Silva, Anne Grabenstetter, Sahar Jalali, Andrea M Gazzo, Higinio Dopeso, Antonio Marra, David N Brown, Dara S Ross, Diana Mandelker, Pedram Razavi, Sarat Chandarlapaty, Hannah Y Wen, Edi Brogi, Hong Zhang, Britta Weigelt, Fresia Pareja, Jorge S Reis-Fil |
How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism. Human genetics 2023 10 . Wanxue Xu, Lacey Plummer, Stephanie B Seminara, Ravikumar Balasubramanian, Margaret F Lippinco |
The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
Whole-exome sequencing of rectal neuroendocrine tumors. Endocrine-related cancer 2023 1 . Li Yuanliang, Guo Yiying, Cheng Zixuan, Tian Chao, Chen Yingying, Chen Ruao, Yu Fuhuan, Shi Yanfen, Su Fei, Zhao Shuhua, Wang Zhizheng, Luo Jie, Tan Huangyi |
Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 2024 5 . Jordi Rodón, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goy |
Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology 2024 5 . Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Gregory J Kirkner, Liam F Spurr, Marie Claire Remolano, Sarah Strauss, Janet Files, Anne-Marie Feeney, Libby Grant, Ayesha Mohammed-Abreu, Ana Garrido-Castro, Romualdo Barroso Sousa, Brittany Bychkovsky, Faina Nakhlis, Jennifer R Bellon, Tari A King, Eric P Winer, Neal Lindeman, Bruce E Johnson, Lynette Sholl, Deborah Dillon, Beth Overmoyer, Sara M Tolaney, Andrew Cherniack, Nancy U Lin, Filipa Lyn |
An integrative framework to prioritize genes in more than 500 loci associated with body mass index. American journal of human genetics 2024 5 . Daiane Hemerich, Victor Svenstrup, Virginia Diez Obrero, Michael Preuss, Arden Moscati, Joel N Hirschhorn, Ruth J F Lo |
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 2024 5 . Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Andrea Casadei-Gardini, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent Pu |
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
Clinical manifestations and spermatogenesis outcomes in Chinese patients with congenital hypogonadotropic hypogonadism caused by inherited or de novo FGFR1 mutations. Asian journal of andrology 2024 1 . Yu-Fan Yang, Hai-Lu Ma, Xi Wang, Min Nie, Jiang-Feng Mao, Xue-Yan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 03, 2024
- Content source: